Risk of Gadolinium-Based Contrast Agents in Chronic Kidney Disease-Is Zero Good Enough?
- PMID: 31816006
- DOI: 10.1001/jamainternmed.2019.5278
Risk of Gadolinium-Based Contrast Agents in Chronic Kidney Disease-Is Zero Good Enough?
Comment on
-
Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent: A Systematic Review and Meta-analysis.JAMA Intern Med. 2020 Feb 1;180(2):223-230. doi: 10.1001/jamainternmed.2019.5284. JAMA Intern Med. 2020. PMID: 31816007 Free PMC article.
Similar articles
-
Use of Gadolinium-Based Contrast Agents in Kidney Disease Patients: Time for Change.Am J Kidney Dis. 2020 Sep;76(3):436-439. doi: 10.1053/j.ajkd.2020.03.011. Epub 2020 Apr 10. Am J Kidney Dis. 2020. PMID: 32283121 No abstract available.
-
Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure.Best Pract Res Clin Rheumatol. 2012 Aug;26(4):489-503. doi: 10.1016/j.berh.2012.07.008. Best Pract Res Clin Rheumatol. 2012. PMID: 23040363 Review.
-
Safety of Contrast Material Use in Children.Magn Reson Imaging Clin N Am. 2017 Nov;25(4):779-785. doi: 10.1016/j.mric.2017.06.009. Epub 2017 Sep 8. Magn Reson Imaging Clin N Am. 2017. PMID: 28964467 Review.
-
Prophylactic Hemodialysis for Protection Against Gadolinium-Induced Nephrogenic Systemic Fibrosis: A Doll's House.Adv Chronic Kidney Dis. 2017 May;24(3):133-135. doi: 10.1053/j.ackd.2017.03.007. Adv Chronic Kidney Dis. 2017. PMID: 28501073 No abstract available.
-
Recent topics related to nephrogenic systemic fibrosis associated with gadolinium-based contrast agents.Int J Urol. 2012 Sep;19(9):806-11. doi: 10.1111/j.1442-2042.2012.03042.x. Epub 2012 May 9. Int J Urol. 2012. PMID: 22571387 Review.
Cited by
-
Use of Intravenous Gadolinium-Based Contrast Media in Patients With Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation.Kidney Med. 2020 Nov 10;3(1):142-150. doi: 10.1016/j.xkme.2020.10.001. eCollection 2021 Jan-Feb. Kidney Med. 2020. PMID: 33604544 Free PMC article. Review.
-
Gadolinium contrast agents- challenges and opportunities of a multidisciplinary approach: Literature review.Eur J Radiol Open. 2023 Jul 4;11:100503. doi: 10.1016/j.ejro.2023.100503. eCollection 2023 Dec. Eur J Radiol Open. 2023. PMID: 37456927 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical